EMERTIA_verde_sinfondo.png
Emerita Resources Enters Into Option Agreement to Acquire Lithium Project
June 13, 2016 08:00 ET | Emerita Resources Corp.
TORONTO, ONTARIO--(Marketwired - June 13, 2016) - Emerita Resources Corp. (the "Company" or "Emerita") (TSX VENTURE:EMO) is pleased to announce that it has entered into a binding letter...
INTL FCStone Ltd.'s Global Payments Division Issues Operational Update; Growth Continues Through First Quarter Calendar Year 2016
June 13, 2016 08:00 ET | INTL FCStone Inc.
LONDON, UNITED KINGDOM--(Marketwired - Jun 13, 2016) - INTL FCStone Inc. (NASDAQ: INTL) Facilitated ~101,000 payments in CY Q1 2016; an increase of ~14% vs. CY Q1...
Redonnez la vie, donnez du sang!
June 13, 2016 08:00 ET | Canadian Blood Services
OTTAWA, ON--(Marketwired - 13 juin 2016) - Pour marquer la Semaine nationale du don de sang, qui a lieu du 13 au 18 juin, la Société canadienne du sang célèbre les donneurs de sang répartis aux quatre...
Canadian Blood Services: To Give Life, Become a Blood Donor
June 13, 2016 08:00 ET | Canadian Blood Services
OTTAWA, ON--(Marketwired - June 13, 2016) - To mark National Blood Donor Week, Canadian Blood Services is celebrating blood donors from across the country who make a lifesaving difference to patients...
CoreCivic, Inc..jpg
CCA Appoints Scott Irwin to Succeed Steve Groom as General Counsel
June 13, 2016 08:00 ET | Corrections Corporation of America
NASHVILLE, Tenn., June 13, 2016 (GLOBE NEWSWIRE) -- Corrections Corporation of America (NYSE:CXW) (the “Company” or “CCA”), America's largest owner of partnership correctional, detention, and...
Fibrocell Announces
Fibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
June 13, 2016 08:00 ET | Fibrocell Science, Inc.
EXTON, Pa., June 13, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for...
Independent Data Mon
Independent Data Monitoring Committee Recommends Continuation of ADAPT Phase 3 Clinical Trial of AGS-003 in Metastatic Renal Cell Carcinoma Following Interim Data Review
June 13, 2016 08:00 ET | Argos Therapeutics Inc.
Positive outcome triggers the second tranche of the Company’s previously announced financing agreement Argos Therapeutics to host conference call with the trial’s co-principal investigator,...
Valeritas Announces Positive Results in Four Studies on V-Go® Disposable Insulin Delivery Device at ADA 2016
June 13, 2016 08:00 ET | Valeritas, Inc.
BRIDGEWATER, N.J., June 13, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today positive results from four studies discussing the clinical and cost benefits of the...
CytomX Logo.jpg
CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors
June 13, 2016 08:00 ET | CytomX Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of...
micron-logo_black_rgb.png
Micron Technology CFO Ernie Maddock to Present June 16 at NASDAQ 34th Investor Program
June 13, 2016 08:00 ET | Micron Technology, Inc.
BOISE, Idaho, June 13, 2016 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) Chief Financial Officer Ernie Maddock will present on Thursday, June 16, at the NASDAQ 34th Investor Program in...